Treatment of lipoprotein disorders in women: proceedings of a workshop held in Frankfurt, October 8 - 9, 1993
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Auckland u.a.
Adis Internat.
1994
|
Schriftenreihe: | Drugs / Supplement
47,2 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | 77 S. Ill., graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV009570691 | ||
003 | DE-604 | ||
005 | 20100330 | ||
007 | t | ||
008 | 940505s1994 ad|| |||| 10||| engod | ||
035 | |a (OCoLC)31455617 | ||
035 | |a (DE-599)BVBBV009570691 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-19 |a DE-12 |a DE-355 | ||
245 | 1 | 0 | |a Treatment of lipoprotein disorders in women |b proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 |c guest ed. G. Baggio ... |
264 | 1 | |a Auckland u.a. |b Adis Internat. |c 1994 | |
300 | |a 77 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Drugs / Supplement |v 47,2 | |
500 | |a Literaturangaben | ||
650 | 7 | |a Lipoproteïnen |2 gtt | |
650 | 7 | |a Stofwisseling |2 gtt | |
650 | 7 | |a Stoornissen |2 gtt | |
650 | 7 | |a Vrouwen |2 gtt | |
650 | 4 | |a Frau | |
650 | 4 | |a Anticholesteremic Agents |x therapeutic use |v Congresses | |
650 | 4 | |a Cardiovascular Diseases |x prevention & control |v Congresses | |
650 | 4 | |a Estrogen Replacement Therapy |x pharmacology |v Congresses | |
650 | 4 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors |v Congresses | |
650 | 4 | |a Lipoidproteinosis |x drug therapy |v Congresses | |
650 | 0 | 7 | |a Lipoproteidstoffwechselstörung |0 (DE-588)4194926-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Östrogene |0 (DE-588)4075616-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Postmenopause |0 (DE-588)4175456-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hormontherapie |0 (DE-588)4025870-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Frau |0 (DE-588)4018202-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Fluvastatin |0 (DE-588)4392565-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1993 |z Frankfurt am Main |2 gnd-content | |
689 | 0 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
689 | 0 | 1 | |a Frau |0 (DE-588)4018202-2 |D s |
689 | 0 | 2 | |a Fluvastatin |0 (DE-588)4392565-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Postmenopause |0 (DE-588)4175456-6 |D s |
689 | 1 | 1 | |a Östrogene |0 (DE-588)4075616-6 |D s |
689 | 1 | 2 | |a Hormontherapie |0 (DE-588)4025870-1 |D s |
689 | 1 | 3 | |a Kardiovaskuläre Krankheit |0 (DE-588)4024666-8 |D s |
689 | 1 | 4 | |a Prävention |0 (DE-588)4076308-0 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Lipoproteidstoffwechselstörung |0 (DE-588)4194926-2 |D s |
689 | 2 | 1 | |a Frau |0 (DE-588)4018202-2 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Baggio, Giovannella |e Sonstige |4 oth | |
810 | 2 | |a Supplement |t Drugs |v 47,2 |w (DE-604)BV000904909 |9 47,2 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-006323257 |
Datensatz im Suchindex
_version_ | 1804123911486439424 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV009570691 |
ctrlnum | (OCoLC)31455617 (DE-599)BVBBV009570691 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02698nam a2200673 cb4500</leader><controlfield tag="001">BV009570691</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100330 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940505s1994 ad|| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31455617</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009570691</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment of lipoprotein disorders in women</subfield><subfield code="b">proceedings of a workshop held in Frankfurt, October 8 - 9, 1993</subfield><subfield code="c">guest ed. G. Baggio ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland u.a.</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">77 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs / Supplement</subfield><subfield code="v">47,2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipoproteïnen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stofwisseling</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stoornissen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vrouwen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Frau</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticholesteremic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Estrogen Replacement Therapy</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hydroxymethylglutaryl-CoA Reductase Inhibitors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoidproteinosis</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipoproteidstoffwechselstörung</subfield><subfield code="0">(DE-588)4194926-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Östrogene</subfield><subfield code="0">(DE-588)4075616-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Postmenopause</subfield><subfield code="0">(DE-588)4175456-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Frau</subfield><subfield code="0">(DE-588)4018202-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Fluvastatin</subfield><subfield code="0">(DE-588)4392565-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1993</subfield><subfield code="z">Frankfurt am Main</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Frau</subfield><subfield code="0">(DE-588)4018202-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Fluvastatin</subfield><subfield code="0">(DE-588)4392565-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Postmenopause</subfield><subfield code="0">(DE-588)4175456-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Östrogene</subfield><subfield code="0">(DE-588)4075616-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Kardiovaskuläre Krankheit</subfield><subfield code="0">(DE-588)4024666-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Lipoproteidstoffwechselstörung</subfield><subfield code="0">(DE-588)4194926-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Frau</subfield><subfield code="0">(DE-588)4018202-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baggio, Giovannella</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">Drugs</subfield><subfield code="v">47,2</subfield><subfield code="w">(DE-604)BV000904909</subfield><subfield code="9">47,2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006323257</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1993 Frankfurt am Main gnd-content |
genre_facet | Konferenzschrift 1993 Frankfurt am Main |
id | DE-604.BV009570691 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:37:17Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006323257 |
oclc_num | 31455617 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR |
owner_facet | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR |
physical | 77 S. Ill., graph. Darst. |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Adis Internat. |
record_format | marc |
series2 | Drugs / Supplement |
spelling | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 guest ed. G. Baggio ... Auckland u.a. Adis Internat. 1994 77 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drugs / Supplement 47,2 Literaturangaben Lipoproteïnen gtt Stofwisseling gtt Stoornissen gtt Vrouwen gtt Frau Anticholesteremic Agents therapeutic use Congresses Cardiovascular Diseases prevention & control Congresses Estrogen Replacement Therapy pharmacology Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Lipoidproteinosis drug therapy Congresses Lipoproteidstoffwechselstörung (DE-588)4194926-2 gnd rswk-swf Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd rswk-swf Östrogene (DE-588)4075616-6 gnd rswk-swf Postmenopause (DE-588)4175456-6 gnd rswk-swf Hormontherapie (DE-588)4025870-1 gnd rswk-swf Frau (DE-588)4018202-2 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf Fluvastatin (DE-588)4392565-0 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1993 Frankfurt am Main gnd-content Hyperlipidämie (DE-588)4161072-6 s Frau (DE-588)4018202-2 s Fluvastatin (DE-588)4392565-0 s DE-604 Postmenopause (DE-588)4175456-6 s Östrogene (DE-588)4075616-6 s Hormontherapie (DE-588)4025870-1 s Kardiovaskuläre Krankheit (DE-588)4024666-8 s Prävention (DE-588)4076308-0 s Lipoproteidstoffwechselstörung (DE-588)4194926-2 s Baggio, Giovannella Sonstige oth Supplement Drugs 47,2 (DE-604)BV000904909 47,2 |
spellingShingle | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 Lipoproteïnen gtt Stofwisseling gtt Stoornissen gtt Vrouwen gtt Frau Anticholesteremic Agents therapeutic use Congresses Cardiovascular Diseases prevention & control Congresses Estrogen Replacement Therapy pharmacology Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Lipoidproteinosis drug therapy Congresses Lipoproteidstoffwechselstörung (DE-588)4194926-2 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd Östrogene (DE-588)4075616-6 gnd Postmenopause (DE-588)4175456-6 gnd Hormontherapie (DE-588)4025870-1 gnd Frau (DE-588)4018202-2 gnd Prävention (DE-588)4076308-0 gnd Hyperlipidämie (DE-588)4161072-6 gnd Fluvastatin (DE-588)4392565-0 gnd |
subject_GND | (DE-588)4194926-2 (DE-588)4024666-8 (DE-588)4075616-6 (DE-588)4175456-6 (DE-588)4025870-1 (DE-588)4018202-2 (DE-588)4076308-0 (DE-588)4161072-6 (DE-588)4392565-0 (DE-588)1071861417 |
title | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 |
title_auth | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 |
title_exact_search | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 |
title_full | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 guest ed. G. Baggio ... |
title_fullStr | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 guest ed. G. Baggio ... |
title_full_unstemmed | Treatment of lipoprotein disorders in women proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 guest ed. G. Baggio ... |
title_short | Treatment of lipoprotein disorders in women |
title_sort | treatment of lipoprotein disorders in women proceedings of a workshop held in frankfurt october 8 9 1993 |
title_sub | proceedings of a workshop held in Frankfurt, October 8 - 9, 1993 |
topic | Lipoproteïnen gtt Stofwisseling gtt Stoornissen gtt Vrouwen gtt Frau Anticholesteremic Agents therapeutic use Congresses Cardiovascular Diseases prevention & control Congresses Estrogen Replacement Therapy pharmacology Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Lipoidproteinosis drug therapy Congresses Lipoproteidstoffwechselstörung (DE-588)4194926-2 gnd Kardiovaskuläre Krankheit (DE-588)4024666-8 gnd Östrogene (DE-588)4075616-6 gnd Postmenopause (DE-588)4175456-6 gnd Hormontherapie (DE-588)4025870-1 gnd Frau (DE-588)4018202-2 gnd Prävention (DE-588)4076308-0 gnd Hyperlipidämie (DE-588)4161072-6 gnd Fluvastatin (DE-588)4392565-0 gnd |
topic_facet | Lipoproteïnen Stofwisseling Stoornissen Vrouwen Frau Anticholesteremic Agents therapeutic use Congresses Cardiovascular Diseases prevention & control Congresses Estrogen Replacement Therapy pharmacology Congresses Hydroxymethylglutaryl-CoA Reductase Inhibitors Congresses Lipoidproteinosis drug therapy Congresses Lipoproteidstoffwechselstörung Kardiovaskuläre Krankheit Östrogene Postmenopause Hormontherapie Prävention Hyperlipidämie Fluvastatin Konferenzschrift 1993 Frankfurt am Main |
volume_link | (DE-604)BV000904909 |
work_keys_str_mv | AT baggiogiovannella treatmentoflipoproteindisordersinwomenproceedingsofaworkshopheldinfrankfurtoctober891993 |